Jump to main content
Jump to site search

Issue 2, 2020
Previous Article Next Article

Ambient mass spectrometry for the molecular diagnosis of lung cancer

Author affiliations

Abstract

Lung cancer is one of the most common malignancies and the leading cause of cancer-related death worldwide. Among the technologies suitable for the rapid and accurate molecular diagnosis of lung cancer, ambient mass spectrometry (AMS) has gained increasing interest as it allows the direct profiling of molecular information from various biological samples (e.g., tissue, serum, urine and sputum) in real-time and with minimal or no sample pretreatment. This minireview summarizes the applications of AMS in lung cancer studies (including tissue molecular identification, the discovery of potential biomarkers, and surgical margin assessment), and discusses the challenges and perspectives of AMS in the clinical precision molecular diagnosis of lung cancer.

Graphical abstract: Ambient mass spectrometry for the molecular diagnosis of lung cancer

Back to tab navigation

Article information


Submitted
19 Jul 2019
Accepted
25 Nov 2019
First published
27 Nov 2019

Analyst, 2020,145, 313-320
Article type
Minireview

Ambient mass spectrometry for the molecular diagnosis of lung cancer

H. Lu, H. Zhang, Y. Wei and H. Chen, Analyst, 2020, 145, 313
DOI: 10.1039/C9AN01365B

Social activity

Search articles by author

Spotlight

Advertisements